Navamedic ASA Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	45	48	39	57	57	55
Market Cap Growth	18.69%	24.95%	-32.08%	-0.50%	2.95%	99.11%
Enterprise Value	57	70	45	64	59	56
Last Close Price	1.84	1.81	2.08	3.20	3.19	3.00
PE Ratio	-	-	-	-	20.43	899.28
PS Ratio	0.94	1.01	0.85	1.24	1.57	2.00
PB Ratio	1.59	1.71	2.10	3.10	2.87	3.68
P/TBV Ratio	-	-	-	-	7.67	8.84
P/FCF Ratio	-	23.59	12.60	-	38.32	-
P/OCF Ratio	21.95	23.59	11.54	292.27	33.51	-
EV/Sales Ratio	1.13	1.47	1.01	1.41	1.64	2.02
EV/EBITDA Ratio	13.39	17.45	12.30	14.65	12.60	34.77
EV/EBIT Ratio	39.23	51.11	16.81	18.17	14.07	49.01
EV/FCF Ratio	-	34.34	14.83	-	39.84	-
Debt / Equity Ratio	0.62	0.62	0.55	0.74	0.28	0.31
Debt / EBITDA Ratio	4.37	4.37	2.55	2.96	1.14	2.57
Debt / FCF Ratio	8.61	8.61	3.29	-	3.74	-
Net Debt / Equity Ratio	0.40	0.40	0.38	0.56	0.02	-0.04
Net Debt / EBITDA Ratio	2.82	2.82	1.87	2.34	0.07	-0.37
Net Debt / FCF Ratio	5.54	5.54	2.26	-6045.00	0.22	2.96
Asset Turnover	0.94	0.94	1.09	1.15	1.07	0.94
Inventory Turnover	3.48	3.48	3.48	3.39	3.09	3.21
Quick Ratio	0.83	0.83	0.66	0.49	0.90	0.78
Current Ratio	1.55	1.55	1.42	1.11	1.93	1.51
Return on Equity (ROE)	-8.55%	-8.55%	-2.60%	-6.59%	16.31%	0.44%
Return on Assets (ROA)	1.68%	1.68%	4.08%	5.57%	7.79%	2.43%
Return on Invested Capital (ROIC)	3.47%	4.24%	10.29%	14.86%	17.17%	2.33%
Return on Capital Employed (ROCE)	2.90%	2.90%	9.70%	12.50%	17.30%	5.90%
Earnings Yield	-4.43%	-4.12%	-1.21%	-2.15%	4.90%	0.11%
FCF Yield	-	4.24%	7.94%	-0.00%	2.61%	-0.36%
Buyback Yield / Dilution	-	-	-1.24%	-1.48%	-3.60%	-13.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.